• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Main Content

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology

    A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness

    Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes

    Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month

    Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

    Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Drug Tech

Eli Lilly

Lilly to submit once-weekly insulin for regulatory review this year following strong clinical results

Eli Lilly (NYSE:LLY) today announced positive safety and efficacy data for its investigational once-weekly insulin efsitora alfa (efsitora). The QWINT-1, QWINT-3 and QWINT-4 Phase 3 clinical trials evaluated efsitora in adults with type 2 diabetes … [Read More...] about Lilly to submit once-weekly insulin for regulatory review this year following strong clinical results

Today on Drug Delivery Business

  • Lilly to submit once-weekly insulin for regulatory review this year following strong clinical results
  • Study finds MannKind inhaled insulin safe, effective for children
  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Sponsored Content

Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI

September 6, 2023 By Sponsored Content

Manufacturing automation is crucial to achieving the precision, quality, and volume required in the medical device industry. Advanced robotics, AI, modular designs, and wireless technology offer the … [Read More...] about Introduce New Drug Delivery Medical Devices with Lower Risk and Higher ROI

More Sponsored Content >>

Featured Posts

GlucoTrack implantable continuous blood glucose monitor CBGM

A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology

June 22, 2025 By Sean Whooley

Glucotrack (Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely. That's according to the company's Chief Scientific Officer, Mark Tapsak, who gave a presentation on the … [Read More...] about A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology

Dexcom and Oura partnered to combine insights using the Dexcom Stelo CGM and Oura ring with a mobile app, all pictured here alongside a meal.

Dexcom continues advances in AI for CGM, type 2 diabetes awareness

June 22, 2025 By Sean Whooley

As one of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its capabilities. The company has hit a number of milestones recently, including updated CGMs, new AI capabilities, expanded … [Read More...] about Dexcom continues advances in AI for CGM, type 2 diabetes awareness

Tandem Diabetes Care t-slim X2 Dexcom G7

Tandem continues to deliver more options, benefits for those with diabetes

June 22, 2025 By Sean Whooley

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon. The San Diego-based automated insulin delivery system developer offers two differentiated pump platforms — the … [Read More...] about Tandem continues to deliver more options, benefits for those with diabetes

sequel twiist automated insulin delivery AID system

Breaking: Sequel to launch twiist automated insulin delivery system next month

June 21, 2025 By Sean Whooley

Sequel Med Tech announced at the American Diabetes Association's 85th Scientific Sessions in Chicago that it plans to launch its twiist system in July. Dr. Joanna Mitri, the company's chief medical officer, shared the update in a Product Theater … [Read More...] about Breaking: Sequel to launch twiist automated insulin delivery system next month

Dexcom G7 CGM Apple Watch direct-to-watch

Dexcom shares U.S. report on CGM benefits for type 2 diabetes

June 21, 2025 By Sean Whooley

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S. The company released its report — "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" — ahead of the … [Read More...] about Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Tandem Diabetes Care t:slim 2 Control-IQ artificial pancreas

Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes

June 20, 2025 By Sean Whooley

A new study showed improved glucose control in pregnant women using Tandem Diabetes Care (Nasdaq:TNDM) insulin delivery technology. The study showed that pregnant women with type 1 diabetes stayed in the target glucose range for pregnancy more … [Read More...] about Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes

Medtronic Simplera Sync CGM with MiniMed 780G (1)

Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications

June 20, 2025 By Sean Whooley

Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of patients. The medtech giant highlighted improved glycemic outcomes for those with type 2 diabetes and in young children. … [Read More...] about Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications

Abbott FreeStyle Libre 3 sensor pennies CGM diabetes

Abbott could pave new roads in diabetes management with dual sensor on the horizon

June 20, 2025 By Sean Whooley

About three years ago, Abbott (NYSE:ABT) announced that it had a new diabetes-related biowearable under development. The technology — a dual sensor that continuously monitors glucose and ketone levels — already had FDA breakthrough device … [Read More...] about Abbott could pave new roads in diabetes management with dual sensor on the horizon

Tandem t_slim X2 Abbott FreeStyle Libre 3

Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.

June 20, 2025 By Sean Whooley

Tandem Diabetes Care (Nasdaq:TNDM) announced today that its t:slim X2 system now works with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus. This marks the latest pairing of automated insulin delivery (AID) and continuous glucose monitor (CGM) … [Read More...] about Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.

mylife loop camdiab ypsomed abbott freestyle libre 3

Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system

June 20, 2025 By Sean Whooley

Ypsomed and CamDiab announced today that they agreed to integrate their mylife Loop automated insulin delivery system with a future Abbott (NYSE:ABT) sensor. The companies plan to pair their pump system with the Abbott dual glucose-ketone sensor, … [Read More...] about Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system

In case you missed it

  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • CeQur hits insulin patch milestone, highlights commercial expansion
  • Zyno recalls certain infusion pumps due to software issue
  • Ypsomed, CamDiab continue global insulin pump iPhone software rollout
  • Dexcom has a Class I CGM receiver recall
  • Medtronic to invest $50M in India Diabetes center
  • Flat Medical partners with Mercury Medical on smart syringe distribution
  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor
  • Mosanna launches with $80M to support nasal spray for obstructive sleep apnea
  • Roche, IBM collab on predictive AI for CGM tech

Clinical Trials

Eli Lilly

Lilly to submit once-weekly insulin for regulatory review this year following strong clinical results

Eli Lilly (NYSE:LLY) today announced positive safety and efficacy data for its investigational once-weekly insulin efsitora alfa (efsitora). The QWINT-1, QWINT-3 and QWINT-4 Phase 3 clinical trials evaluated efsitora in adults with type 2 diabetes who used insulin for the first time, previously used daily basal insulin, and previously used daily basal insulin and mealtime insulin, […]

MannKind afrezza inhaled insulin in use

Study finds MannKind inhaled insulin safe, effective for children

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with type 1 diabetes. Investigators presented findings from the INHALE-1 study as a symposium at the American Diabetes Association’s 85th Scientific Sessions. The data showed that inhaled insulin offers a safe and effective replacement for rapid-acting meal insulin […]

GlucoTrack implantable continuous blood glucose monitor CBGM

A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology

Glucotrack (Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren’t being served completely. That’s according to the company’s Chief Scientific Officer, Mark Tapsak, who gave a presentation on the company’s long-term implantable continuous blood glucose monitor (CBGM) as part of the American Diabetes Association’s 85th Scientific Sessions’ “Innovation […]

Tandem Diabetes Care t:slim 2 Control-IQ artificial pancreas

Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes

A new study showed improved glucose control in pregnant women using Tandem Diabetes Care (Nasdaq:TNDM) insulin delivery technology. The study showed that pregnant women with type 1 diabetes stayed in the target glucose range for pregnancy more with the Tandem t:slim X2 automated insulin delivery system with Control-IQ technology compared to standard insulin delivery with injections […]

Medtronic Simplera Sync CGM with MiniMed 780G (1)

Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications

Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of patients. The medtech giant highlighted improved glycemic outcomes for those with type 2 diabetes and in young children. Investigators shared data at the American Diabetes Association’s 85th Scientific Sessions in Chicago. In one study, participants […]

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS